Clincosm LogoSign in Get a demo

Acute Myelogenous Leukemia

Showing 76 - 100 of 203
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myelogenous Leukemia Trial in Houston (Plerixafor, Clofarabine)

Terminated
Has Results
  • Acute Myelogenous Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Aug 19, 2019

MRI Assessment of Leukemia Response to Therapy

Completed
  • Acute Myelogenous Leukemia
  • 3 Tesla (3T) Siemens Total imaging matrix (TIM) Trio whole-body system
  • Portland, Oregon
    Oregon Health and Science University
Jul 27, 2019

Medium Dose of Cytarabine and Mitoxantrone

Unknown status
  • Acute Myelogenous Leukemia
  • Chemotherapy
  • Flow Cytometer
  • +2 more
  • Shenzhen, Guangdong, China
    Shenzhen
Jul 16, 2019

Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome Trial in Philadelphia (Non-myeloablative

Completed
  • Acute Myelogenous Leukemia
  • +2 more
  • Non-myeloablative allogeneic stem cell transplant with prophylactic activated DLI
  • +2 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center at University of Pennsylvania
Jul 10, 2019

Acute Myelogenous Leukemia Trial in United States (GRNVAC1)

Completed
  • Acute Myelogenous Leukemia
  • GRNVAC1
  • Atlanta, Georgia
  • +5 more
Jul 2, 2019

Acute Myelogenous Leukemia Trial in Seoul (allogeneic, donor-derived NK cells)

Terminated
  • Acute Myelogenous Leukemia
  • allogeneic, donor-derived NK cells
  • Seoul, Korea, Republic of
    Asan Medical Center
Jul 5, 2019

Acute Myeloid Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in United States (FT-1101, Azacitidine)

Completed
  • Acute Myeloid Leukemia
  • +3 more
  • Los Angeles, California
  • +7 more
Jun 25, 2019

Acute Myeloid Leukemia, Acute Myelogenous Leukemia Trial in Canada, United States (Azacitidine, Lenalidomide, Best Supportive

Completed
Has Results
  • Acute Myeloid Leukemia
  • Acute Myelogenous Leukemia
  • Tucson, Arizona
  • +29 more
Jun 17, 2019

Myelodysplastic Syndrome, Acute Myelogenous Leukemia Trial in Houston (Decitabine, Valproic Acid)

Completed
Has Results
  • Myelodysplastic Syndrome
  • Acute Myelogenous Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
May 2, 2019

Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in United States (BVD-523)

Completed
Has Results
  • Acute Myelogenous Leukemia
  • Myelodysplastic Syndrome
  • Los Angeles, California
  • +4 more
Jan 9, 2019

Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma, Multiple Myeloma Trial in Boston (drug, radiation, biological)

Completed
Has Results
  • Non-Hodgkin's Lymphoma
  • +4 more
  • Boston, Massachusetts
  • +2 more
Dec 29, 2018

Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Minneapolis (iTreg)

Completed
  • Acute Myelogenous Leukemia
  • +7 more
  • iTreg
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Jan 17, 2019

Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Houston (Gelonin, Busulfan, Fludarabine)

Terminated
  • Acute Myelogenous Leukemia
  • Myelodysplastic Syndrome
  • Gelonin
  • +2 more
  • Houston, Texas
    UT MD Anderson Cancer Center
Oct 30, 2018

Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia Trial (Dendritic Cell Activated Lymphocyte)

Withdrawn
  • Acute Myelogenous Leukemia
  • Chronic Myelogenous Leukemia
  • Dendritic Cell Activated Lymphocyte
  • (no location specified)
Oct 24, 2018

Acute Myelogenous Leukemia, MDS Trial in Jacksonville, Lebanon (Melphalan, Bortezomib, Melphalan and bortezomib)

Completed
Has Results
  • Acute Myelogenous Leukemia
  • Myelodysplastic Syndromes
  • Jacksonville, Florida
  • +1 more
Oct 22, 2018

Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Duarte, Lexington (PD-616)

Terminated
  • Acute Myelogenous Leukemia
  • Myelodysplastic Syndrome
  • Duarte, California
  • +1 more
Jul 23, 2018

Acute Myelogenous Leukemia, Myelodysplastic Syndrome, Acute Lymphocytic Leukemia Trial in New York (device, drug, procedure)

Terminated
Has Results
  • Acute Myelogenous Leukemia
  • +4 more
  • CliniMACS® CD34 Reagent System
  • +5 more
  • New York, New York
    Weill Cornell Medical College
Jun 12, 2018

Prognostic Importance of Polypharmacy in Adults Treated for

Completed
  • ACUTE MYELOGENOUS LEUKEMIA
  • No Intervention
  • (no location specified)
Jun 29, 2018

ACUTE MYELOGENOUS LEUKEMIA Trial (Bedside assessment)

Completed
  • ACUTE MYELOGENOUS LEUKEMIA
  • Bedside assessment
  • (no location specified)
Jun 29, 2018

Relapsed Malignant Blood Cancer After Allogeneic Hematopoietic

Terminated
Has Results
  • Chronic Myelogenous Leukemia
  • +4 more
  • Allogeneic stem cell transplant
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
May 3, 2018

Acute Myelogenous Leukemia, AML, Acute Myeloid Leukemia Trial (ABT-199)

Completed
Has Results
  • Acute Myelogenous Leukemia
  • +2 more
  • (no location specified)
May 2, 2018

Acute Myelogenous Leukemia, MDS Trial in United States (Phase 1 - OXi4503, Phase 1 - OXi4503 + cytarabine, Phase 2 - OXi4503 +

Unknown status
  • Acute Myelogenous Leukemia
  • Myelodysplastic Syndromes
  • Phase 1 - OXi4503
  • +2 more
  • Los Angeles, California
  • +3 more
Jun 1, 2018

Acute Myelogenous Leukemia, Myelodysplastic Syndrome, Leukemia Trial in Houston (Procrit)

Completed
Has Results
  • Acute Myelogenous Leukemia
  • +2 more
  • Houston, Texas
    The University of Texas M.D. Anderson Cancer Center
May 1, 2018

Acute Myelogenous Leukemia, High-Grade Myelodysplastic Syndrome Trial in Morristown (Alisertib)

Completed
Has Results
  • Acute Myelogenous Leukemia
  • High-Grade Myelodysplastic Syndrome
  • Morristown, New Jersey
    Hematology and Oncology Associates of Northern New Jersey
Apr 9, 2018

Acute Myeloid Leukemia, Acute Myelogenous Leukemia Trial in United States (Standard dose cytarabine for induction, SGN-CD33A,

Completed
  • Acute Myeloid Leukemia
  • Acute Myelogenous Leukemia
  • Standard dose cytarabine for induction
  • +3 more
  • Birmingham, Alabama
  • +12 more
May 8, 2018